Acamprosate

Drugs in R and D

Volumn 3, Issue 1, 2002, Pages 13-18

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; DIAZEPAM; DISULFIRAM; IMIPRAMINE; MEPROBAMATE; OXAZEPAM; PHENOBARBITAL; SPIRONOLACTONE; TETRABAMATE; ZULEX; DRUG DERIVATIVE; DRUGS USED IN THE TREATMENT OF ADDICTION; TAURINE;

ABDOMINAL PAIN; ALCOHOLISM; ARTICLE; BULLOUS SKIN DISEASE; CLINICAL TRIAL; CONFUSION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DROWSINESS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; ERYTHEMA; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; HYPOTENSION; LIBIDO DISORDER; NAUSEA AND VOMITING; PRIORITY JOURNAL; PRURITUS; RASH; VERTIGO; DRUG INTERACTION; PSYCHOLOGICAL ASPECT; REVIEW; WITHDRAWAL SYNDROME;

ALCOHOL DETERRENTS; ALCOHOLISM; DRUG INTERACTIONS; HUMANS; SUBSTANCE WITHDRAWAL SYNDROME; TAURINE;

EID: 0036370459     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200203010-00002     Document Type: Article

References (8)

1. Acamprosate for alcohol dependence. Pharmaceutical Journal 1995 Mar 11; 254: 318
2. Zeise ML, Kasparov S, Capogna M, et al. Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitory amino acid receptors. Eur J Pharmacol 1993 Jan 26; 231: 47-52
3. Wilde MI, Wagstaff AJ. Acamprosate: a review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs 1997 Jun; 53: 1038-53
4. Whitworth AB, Fischer F, Lesch OM, et al. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 1996 May 25; 347: 1438-42
5. Fortier-Beaulieu M, Noblet C, Cardot F, et al. Possible association of erythema multiforme with acamprosate. Lancet 1992 Apr 18; 339: 991
6. Tempesta E, Janiri L, Bignamini AA. The effectiveness and safety of calcium-acetylhomotaurinate (acamprosate) on the maintenance of abstinence in weaned alcoholics. Eur Psychiatry 1994; 9 Suppl 1: 203
7. Paille FM, Guelfi JD, Perkins AC, et al. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol and Alcohol 1995 Mar; 30: 239-47
8. Schädlich PK, Brecht JG. The cost effectiveness of acamprosate in the treatment of alcoholism in Germany: economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study. Pharmacoeconomics 1998 Jun; 13: 719-3